A new company spun off from Harvard University aims to simplify data analysis, management, and collaboration for life science researchers. . . . → Read More: New Company Forms to Ease Scientific Data Operations
|
|||||
A new company spun off from Harvard University aims to simplify data analysis, management, and collaboration for life science researchers. . . . → Read More: New Company Forms to Ease Scientific Data Operations The top universities producing women entrepreneurs are much the same as the schools graduating the most start-up founders overall. . . . → Read More: Infographic – Schools Graduating Women Entrepreneurs A company developing non-invasive liquid biopsy tests for cancer received NIH funding to extend that technology for quick Covid-19 virus tests. . . . → Read More: Liquid Biopsy Tech Adapted for Covid-19 Testing Two biotechnology companies are designing new processes to produce ingredients much like those found in drugs made from plants for essential medicines. . . . → Read More: Biotechs Partner on Synthetic Plant-Based Drugs A company producing synthetic RNA for agricultural and biomedical applications is now a public company after a special-purpose acquisition. . . . → Read More: RNA Manufacturer Goes Public in $282M Merger The biotechnology company Moderna Inc. agreed to build a manufacturing plant for its messenger RNA or mRNA vaccines in Canada. . . . → Read More: Moderna to Build mRNA Vaccine Plant in Canada A biotechnology company received a foundation grant for an implanted device to prevent HIV infection and unwanted pregnancy in women. . . . → Read More: Gates Grant Funds HIV-Birth Control Implant Two statistical indicators provide more evidence that innovations in health and medicine are continuing their sharp upward climb. . . . → Read More: Infographic – Biomedical Innovation Gains Continue A low-cost device is being developed that analyzes saliva samples for SARS-CoV-2 viral mutations, and returns results in about one hour. . . . → Read More: Portable Testing Device IDs Covid-19 Variants Drug maker Bayer is acquiring a company discovering new therapies with a technology that reveals complex protein targets considered difficult to address. . . . → Read More: Protein Chemistry Biotech Acquired in $2B Deal |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |